Amgen to Present at the 27th Annual JP Morgan Healthcare Conference
THOUSAND OAKS, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Amgen (Nasdaq:
AMGN) will present at the 27th Annual JP Morgan Global Healthcare Conference
at 9:00 a.m. Pacific Time on Monday, Jan. 12, 2009, at the Westin St. Francis
in San Francisco, Calif. Amgen Chairman and CEO Kevin Sharer will present at
the conference. Live audio of the presentation will be available over the
Internet and can be accessed from Amgen's Web site, www.amgen.com, under
Investors.
(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO )
Information regarding presentation time, webcast availability, and webcast
links are available on Amgen's Investor Relations Events Calendar.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by bringing safe and effective
medicines from lab, to manufacturing plant, to patient. Amgen therapeutics
have changed the practice of medicine, helping millions of people around the
world in the fight against cancer, kidney disease, rheumatoid arthritis, and
other serious illnesses. With a deep and broad pipeline of potential new
medicines, Amgen remains committed to advancing science to dramatically
improve people's lives. To learn more about our pioneering science and our
vital medicines, visit www.amgen.com.
CONTACT: Amgen, Thousand Oaks
David Polk, 805-447-4613 or 805-490-0661 (media)
Arvind Sood, 805-447-1060 (investors)
SOURCE Amgen
